Last updated: February 13, 2026
What is NDC 64380-0116?
NDC 64380-0116 corresponds to Doxycycline Hyclate in 100 mg capsules. It treats bacterial infections and is a broad-spectrum antibiotic within the tetracycline class. The drug is widely used in both outpatient and hospital settings.
Market Overview
Current Market Size and Trends
The global antibiotics market was valued at approximately USD 50 billion in 2022. The doxycycline segment accounts for a significant share due to its broad indications, low cost, and established generic presence.
In the United States, doxycycline prescriptions peaked at around 15 million annually pre-pandemic, driven by respiratory and skin infections. The COVID-19 pandemic temporarily affected antibiotic prescribing but has since normalized.
Competitive Landscape
- Brand-Name Products: Vibramycin (Pfizer), Doryx (Mylan)
- Generics: Multiple manufacturers produce doxycycline capsules and tablets, leading to high price competition.
- Patent Status: No active patents for doxycycline hyclate; generics dominate market segments.
Regulatory Environment
The drug is approved by the FDA, with no recent significant regulatory changes impacting production or approval pathways. Increased antimicrobial stewardship efforts could influence prescribing patterns in the future.
Pricing Dynamics
Current Pricing
| Product Type |
Average Wholesale Price (AWP) per 100-count bottle |
Comments |
| Generic Doxycycline |
USD 10 - USD 15 |
Price varies by supplier, pharmacy discount programs in use |
| Brand Name |
USD 125 - USD 150 |
Rarely used due to high cost |
Market Pricing Factors
- Generic Competition: Saturation keeps prices low.
- Supply Chain Dynamics: Production disruptions or raw material shortages can influence prices temporarily.
- Regulatory Changes: New guidelines or antimicrobial stewardship policies could impact demand, indirectly affecting pricing.
Price Projections (Next 3 Years)
| Year |
Estimated Price Range per 100-count bottle |
Assumptions |
| 2023 |
USD 9 - USD 14 |
Continued generic competition, stable demand |
| 2024 |
USD 9 - USD 14 |
No significant market disruption |
| 2025 |
USD 8 - USD 13 |
Slight downward trend due to increased generic volume |
Factors Influencing Price Trends
- Increased Generic Market Share: Further price pressure.
- Potential Supply Constraints: Could temporarily increase prices.
- Stewardship Policies: May reduce demand for antibiotics, placing downward pressure on prices.
- Emergence of Resistance: Could influence prescribing patterns, affecting market size.
Market Drivers and Risks
Drivers:
- Widespread use for bacterial infections.
- Cost-effectiveness drives prescriber preference.
- Early adoption in prophylactic treatments for certain conditions.
Risks:
- Regulatory and stewardship policies limiting antibiotic use.
- Competition from newer or alternative therapies.
- Rising antimicrobial resistance reducing effectiveness.
Competitive and Supply Chain Risks
The high generic competitiveness stabilizes prices, but supply chain vulnerabilities, such as raw material shortages from geopolitical or manufacturing issues, could temporarily inflate prices. Any patent litigation or exclusivity periods could alter the competitive landscape, but currently, no patent protections inhibit generic production.
Summary of Opportunities
- Potential for market share gains if new indications or formulations are approved.
- Opportunities to optimize supply chain and reduce manufacturing costs to improve margins.
- Entry into emerging markets where antibiotics are underpenetrated.
Summary of Challenges
- Pricing pressure from extensive generic competition.
- Regulatory restrictions on antibiotic prescribing.
- Public health campaigns reducing antibiotic consumption.
Key Takeaways
- NDC 64380-0116 (doxycycline hyclate capsules) operates in a saturated, highly competitive market.
- Prices are trending downward but remain affordable due to the generic landscape.
- Market size is stable but vulnerable to antimicrobial stewardship policies and resistance trends.
- Investment opportunities depend on manufacturing efficiencies and potential new indications.
- Supply chain resilience remains critical to maintaining competitive prices.
FAQs
1. How does the entry of new generic manufacturers impact doxycycline price?
Increased generic entrants usually lead to price decreases due to high market competition, pushing prices closer to manufacturing costs.
2. Can regulatory changes affect doxycycline market prices?
Yes. Policies that restrict antibiotic use or promote stewardship could reduce demand, pressuring prices downward.
3. What factors could cause a temporary price spike?
Supply shortages, raw material disruptions, or manufacturing issues could lead to short-term price increases.
4. Are there patent protections still in effect for doxycycline?
No. Patents for doxycycline have expired, enabling multiple manufacturers to produce generic versions.
5. What new developments could alter this market’s outlook?
Emergence of resistance, new antibacterial agents, or approval of alternative therapies could reduce doxycycline demand.
Citations
[1] MarketsandMarkets, "Antibiotics Market," 2022.
[2] IQVIA, "Prescribing Trends," 2022.
[3] FDA, "Doxycycline Approvals," 2023.
[4] Healthcare Cost and Utilization Project, "Antibiotic Utilization," 2022.
